No price history available.
Key financial summary
Financials in TWD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | TWDm | 667 | 754 | 893 | 662 | 717 | 1,079 | N/A | N/A |
| Operating profit | TWDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | TWDm | 66 | 88 | 158 | 8 | -132 | 65 | N/A | N/A |
| EPS reported | TWD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | TWD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | TWD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | TWD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | TWDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | TWDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | TWDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | TWD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | TWD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in TWD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
IntelliEPI Inc. (Cayman), operating through its subsidiaries, specializes as a manufacturer and supplier of advanced compound semiconductor epitaxy wafers. These specialized components are vital for cutting-edge technologies in wireless communication, data transmission, and national defense applications. The company boasts a global presence, serving key markets including the United States, Germany, China, Japan, and Korea. A cornerstone of its operation is the use of proprietary Molecular Beam Epitaxy (MBE) systems, which integrate real-time in situ growth monitoring technology. This sophisticated manufacturing process enables the creation of high-quality epi-wafers built on Gallium Arsenide (GaAs) and Indium Phosphide (InP) substrates. IntelliEPI's extensive product portfolio encompasses: GaAs-based solutions: Such as pseudo-morphic high electron mobility transistors (pHEMTs) and MHEMT products. InP-based offerings: Including hetero-junction bipolar transistors (HBTs), HEMTs, RTT, and RTD components. Antimony (Sb)-based products: Featuring Type II SLS photodetectors, GaAsSb-based InP HBTs, and epi-ready Gallium Antimonide (GaSb) substrates. Mismatched epitaxy products: Like III-V on Silicon (Si), III-V on Germanium (Ge), and high indium content Indium Gallium Arsenide (InGaAs) on Silicon. Optoelectronic devices: A wide array including avalanche photodiodes (APDs), various types of lasers (such as high-speed high-frequency surface-emitting lasers and quantum cascade lasers), optical receivers, quantum well-infrared photodetectors (QWIPs), modulators, and general infrared light detectors. Established in 1999, IntelliEPI maintains its corporate headquarters in Richardson, Texas.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
IntelliEPI Inc. (Cayman) (4971.TWO)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
IntelliEPI Inc. (Cayman), operating through its subsidiaries, specializes as a manufacturer and supplier of advanced compound semiconductor epitaxy wafers. These specialized components are vital for cutting-edge technologies in wireless communication, data transmission, and national defense applications. The company boasts a global presence, serving key markets including the United States, Germany, China, Japan, and Korea. A cornerstone of its operation is the use of proprietary Molecular Beam Epitaxy (MBE) systems, which integrate real-time in situ growth monitoring technology. This sophisticated manufacturing process enables the creation of high-quality epi-wafers built on Gallium Arsenide (GaAs) and Indium Phosphide (InP) substrates. IntelliEPI's extensive product portfolio encompasses: GaAs-based solutions: Such as pseudo-morphic high electron mobility transistors (pHEMTs) and MHEMT products. InP-based offerings: Including hetero-junction bipolar transistors (HBTs), HEMTs, RTT, and RTD components. Antimony (Sb)-based products: Featuring Type II SLS photodetectors, GaAsSb-based InP HBTs, and epi-ready Gallium Antimonide (GaSb) substrates. Mismatched epitaxy products: Like III-V on Silicon (Si), III-V on Germanium (Ge), and high indium content Indium Gallium Arsenide (InGaAs) on Silicon. Optoelectronic devices: A wide array including avalanche photodiodes (APDs), various types of lasers (such as high-speed high-frequency surface-emitting lasers and quantum cascade lasers), optical receivers, quantum well-infrared photodetectors (QWIPs), modulators, and general infrared light detectors. Established in 1999, IntelliEPI maintains its corporate headquarters in Richardson, Texas.
